Kara Warshaw
Psychiatric/Mental Health · Sulphur, LANPI 1942290200
Payments from drug & device makers
Across 216 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$612
- Neurocrine Biosciences, Inc.$470
- AbbVie$404
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$359
- Alkermes, Inc.$357
- Supernus Pharmaceuticals, Inc.$328
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,97699%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 41 | $612 |
| Neurocrine Biosciences, Inc. | 18 | $470 |
| AbbVie | 27 | $404 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $359 |
| Alkermes, Inc. | 25 | $357 |
| Supernus Pharmaceuticals, Inc. | 9 | $328 |
| Axsome Therapeutics, Inc. | 14 | $325 |
| Teva Pharmaceuticals USA, Inc. | 17 | $278 |
| Indivior Inc. | 13 | $248 |
| Vanda Pharmaceuticals Inc. | 14 | $242 |
| Johnson & Johnson | 6 | $131 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Gilead | 2 | $37 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $16 |
| Corium, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,000 in reported general payments places this provider in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 31 | $253,772 |
| Invega SustennaPaliperidone Palmitate | 18 | $66,392 |
| RexultiBrexpiprazole | 28 | $40,154 |
| Abilify MaintenaAripiprazole | 12 | $37,123 |
| VraylarCariprazine Hcl | 19 | $25,939 |
| TrintellixVortioxetine Hydrobromide | 22 | $11,069 |
| Lurasidone Hcl | 49 | $6,441 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $6,415 |
| Clozapine | 36 | $2,560 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 52 | $1,921 |
| Quetiapine Fumarate | 142 | $1,130 |
| Oxcarbazepine | 45 | $979 |
| Hydroxyzine Pamoate | 55 | $888 |
| Duloxetine Hcl | 100 | $863 |
| Buspirone Hcl | 81 | $850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $470 | $253,77231 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $612 | $77,27640 claims |
| Johnson & JohnsonInvega Sustenna | $131 | $66,39218 claims |
| AbbVieVraylar | $404 | $25,93919 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $21 | $11,06922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Sulphur
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.